BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 1, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2002
View Archived Issues
Sangamo awarded grant to apply ZFP technology to treatment of sickle cell disease
Read More
Bayer Diagnostics to acquire Visible Genetics
Read More
G17DT receives orphan drug status in gastric cancer
Read More
Inhibition of amyloid fibrillation as a target for therapeutic intervention in AD4
Read More
Improving CNS drainage using COGNIShunt system may slow progression of AD
Read More
New formulation of Rapamune introduced in U.K.
Read More
GLI-5021: a novel therapeutic for acute and chronic myocardial ischemia
Read More
KRN-4884 mimics effects of hypoxic preconditioning in coronary preparations
Read More
PST-2744 tested in cardiomyopathic hamster model of heart failure
Read More
PPARgamma ligand protects heart from reperfusion injury
Read More
MCH1 receptor validated as promising target for Rx of obesity, depression and anxiety at Synaptic
Read More
Phase I/II results for VB2-011 encouraging
Read More
Aromatase inhibitor from Yamanouchi withdrawn from development
Read More
Access initiates OraDisc phase III trial, acquires rights to amlexanox
Read More
University of Kentucky researchers present morphine derivatives with analgesic activity
Read More
Oral formulation of YM-087 dropped from development
Read More
Novel bradykinin antagonists identified at Pfizer
Read More
Texas Biotechnology presents novel alpha4beta1 integrin antagonists
Read More
Daiichi discontinues development of nefiracetam in further territories
Read More
Novel antibacterial compounds isolated from Actinomadura sp. cultures
Read More
Integrin antagonists and their use in allergic rhinitis and other disorders
Read More
Merck describes basic research in the area of tyrosine kinase inhibitors
Read More
Thrombin receptor antagonists designed at Merck
Read More
FDA approves Zelnorm for IBS in women with constipation
Read More
Seattle Genetics provides second-quarter update
Read More
Regeneron initiates phase II testing of IL-1 Trap in rheumatoid arthritis
Read More